TrophAmine Articles
Luteolin alleviates neuroinflammation
26 May 2008
Encouraging early findings on Transgene HCV vacc
26 May 2008
FDA accepts Anesiva's Zingo sNDA
26 May 2008
FDA accepts Reloxin BLA, Ipsen gets $25M
26 May 2008
American Oriental up on OTC revenue
19 May 2008
US CDC recommends shingles vaccine for over 60s
19 May 2008
Bayer pulls remaining stocks of Trasylol
19 May 2008
Stock Commentary - Europe - week to May 12, 2008
19 May 2008
Simcere generic biapenem cleared in China
19 May 2008
Ziopharm granted orphan status for STS treatment
19 May 2008
Generics cut King's 1st-qtr income 16%
19 May 2008
VEGF Trap-Eye enters Ph III testing
19 May 2008
J&J drug: longer time to relapse than quetiapine
12 May 2008
Anesiva expands Zingo deal with Sigma-Tau
5 May 2008
FDA clears Teva's Flolan ANDA
5 May 2008
Isis advised on new drug's approval path
5 May 2008
FDA approves Wyeth & Progenics' Relistor
5 May 2008
Genzyme's 1st-qtr revenues jump 25%
5 May 2008
Ph III Acurox trial enrolled
5 May 2008
FDA approval for CV and Astellas' Lexiscan
28 April 2008
China denies heparin contamination
28 April 2008
Galapagos licenses Enceladus RA drug
28 April 2008
Positive results from Teva's PreCISe Copaxone study
28 April 2008
Gilead record sales push revenue up 22%
28 April 2008
EMEA clears histology-based use for Alimta
21 April 2008
New data on Teva's Copaxone positive
21 April 2008
PepTcell's HIV-v vacc enters animal testing
14 April 2008
Stock Commentary - New York week to April 7, 2008
14 April 2008
BTG progresses Varisolve development
14 April 2008
Caraco's launches Sun Pharma's generic Ethyol
14 April 2008
Abraxis pays initial $15M for Shimoda
14 April 2008
Strong Ph II data for Ardana's Teverelix LA
14 April 2008
UK's NICE to finalize approval of Lucentis
7 April 2008
Regeneron's Arcalyst available in USA
31 March 2008
FDA clears Cephalon's Treanda for CLL
31 March 2008
Centocor and S-P submit MAA on golimumab
24 March 2008
Mapreg spinal injury drug gets OD status
24 March 2008
Japan stock market week to March 17, 2008
24 March 2008
Reduced dosage temptation for expensive Gaucher's drug
24 March 2008
FDA seeks confirmatory data on Genasense
24 March 2008
Ipsen/Medicis submit Reloxin BLA to FDA
24 March 2008
Sagent launches generic cefazolin injection
24 March 2008
Injectafar gets FDA non-approvable letter
24 March 2008
Javelin
17 March 2008
FDA extends review of J&J's Doribax
17 March 2008
Pre-filled syringe use growing in range of therapies
10 March 2008
Eisai/MGI's Aloxi gets expanded indication
10 March 2008
New Rebif formulation launched in UK
10 March 2008
Actavis gets OK for generic irinotecan
10 March 2008
Zyprexa LAI gets FDA non-approvable letter
10 March 2008
Regeneron's CAPS drug cleared by FDA
3 March 2008
Elderly urged to change lifestyle to battle AMD
3 March 2008
SCOTUS signals FDA pre-emption support
3 March 2008
Sirolimus impresses in Ph I wet AMD trial
3 March 2008
SEP launches Plenaxis in Germany
3 March 2008
FDA approves Abbott's Humira for JIA
3 March 2008
SCOTUS signals support for FDA pre-emption
3 March 2008
FDA accepts Sanofi's sNDA for Eloxatin
3 March 2008
New histology-based use for Alimta
3 March 2008
CHMP recommends Lilly's Forsteo
3 March 2008
EMEA's CHMP gives nod to Ratiopharm's Ratiograstim
3 March 2008
FDA Treanda decision expected end-October
25 February 2008
NT's fiscal 2nd-qtr loss doubles on Viprinex
25 February 2008
Medrad to acquire Possis for $361M
18 February 2008
EMEA accepts Vidaza for accelerated review
18 February 2008
Six-month Decapeptyl similar to present forms
18 February 2008
Study finds Tasylol safe in certain surgeries
18 February 2008
US FDA opens safety review on Botox
18 February 2008
Baxter issues voluntary heparin recall
4 February 2008
FDA clears Merck & Co's Emend Injection for CINV
4 February 2008
New info on prevalence of HIV in US households
4 February 2008
Lilly's 4th qtr recovers from Zyprexa settlement
4 February 2008
Clexane, and Nexavar in RCC approved in Japan
4 February 2008
China contaminated drug toll reaches 14
28 January 2008
FDA pre-emption case taken up by SCOTUS
28 January 2008
FDA clears APP's Polmyxin B Sulfate
21 January 2008
Medicure's 2nd-qtr sales fall on Aggrastat slump
21 January 2008
Promising Ph IIb data on Transgene NSCLC vacc
21 January 2008
Pharmion files Vidaza MAA with EMEA
21 January 2008
FDA Genasense decision expected this quarter
21 January 2008
Encouraging early AD data with anti-TNF drug
21 January 2008
More NCEs added to Japan's NHI reimbursement list late December
14 January 2008
Japan stock market week to Nov 14
7 January 2008
Barr Labs challenges Argatroban patent
7 January 2008
NeoPharm files IND for novel docetaxel delivery system
7 January 2008
Cephalon seeks NHL indication for Treanda
7 January 2008
Merck Serono and Flamel accord of Medusa technology
7 January 2008
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
